Mirena 20MCG/24HR 1S
Ended Awarded
- Contract number
- SPE2DR26FBTAU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,007
Award facts
- Contract value 100% obligated
- $17,007.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,007.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 20 mcg/24 hr contraceptive devices. The award, issued on November 3, 2025, with an ultimate completion date of November 17, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to provide comprehensive pharmaceutical and medical supply solutions to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with its parent contract SPE2DR featuring a $499.999 billion ceiling value through December 31, 2036. The company's extensive product portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with recent delivery orders spanning diverse therapeutic categories. As a single-award prime vendor contractor under the PPV-G GEN V framework, DMS Pharmaceutical Group serves military healthcare operations globally and has demonstrated substantial performance across multiple contract awards issued by the Defense Logistics Agency's Medical Supply Chain division, with no identified subcontractor relationships.
Quick answers
Who was awarded contract SPE2DR26FBTAU?
SPE2DR26FBTAU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FBTAU worth?
The government has obligated $17,007 on SPE2DR26FBTAU.
Is contract SPE2DR26FBTAU an order under another contract?
Yes. SPE2DR26FBTAU is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTAU competed?
The extent of competition for SPE2DR26FBTAU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award